Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease: Definition and subtypes
Seulki Han, Soon Koo Baik, Moon Young Kim
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S5-S16
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi‐Ae Kim, Joon Ho Moon, Won Kim
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 831-843
Open Access | Times Cited: 72
Not Only Metabolic Complications of Childhood Obesity
Sebastian Ciężki, Emilia Odyjewska, Artur Bossowski, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 539-539
Open Access | Times Cited: 17
Lycopene: A Potent Antioxidant with Multiple Health Benefits
Mercy Omoye Shafe, Nontobeko Myllet Gumede, Trevor Tapiwa Nyakudya, et al.
Journal of Nutrition and Metabolism (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 13
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD
Devaraj Ezhilarasan
Metabolism (2024) Vol. 155, pp. 155912-155912
Closed Access | Times Cited: 12
Hepatic Stellate Cell‐Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis
Lei Wang, Jieying Zhou, Jian Wang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 12
Closed Access | Times Cited: 10
Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise
Thomai Mouskeftara, Olga Deda, Grigorios Papadopoulos, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1494-1494
Open Access | Times Cited: 10
Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and/or alcohol: a nationwide study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 10
The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective
Nikolaus Bresgen, Melanie Kovacs, Angelika Lahnsteiner, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 912-912
Open Access | Times Cited: 18
NUP85 alleviates lipid metabolism and inflammation by regulating PI3K/AKT signaling pathway in nonalcoholic fatty liver disease
Yincui Wu, Qi Yan, Si-qing Yue, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2219-2235
Open Access | Times Cited: 8
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
Yewan Park, Jooyi Jung, Seungbong Han, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 7
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4857-4857
Open Access | Times Cited: 6
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 6
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
Landon L. Chan, Stephen L. Chan
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 909-923
Open Access | Times Cited: 15
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
Salvatore Pezzino, Tonia Luca, M. Castorina, et al.
Life (2024) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 5
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trials
Sadegh Mozaffari, Mahdeyeh Aliari, Solaleh Emamgholipour, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 8, pp. 108780-108780
Closed Access | Times Cited: 5
The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Xiaoyan Li, Jie He, Qiuhua Sun
Clinical Nutrition (2024) Vol. 43, Iss. 9, pp. 2005-2016
Open Access | Times Cited: 5
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
Emilie K. Mitten, Piero Portincasa, György Baffy
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 11
Protective effects of statins on the incidence of NAFLD–related decompensated cirrhosis in T2DM
Szu‐Yuan Wu, Wan‐Ming Chen, Ming‐Feng Chiang, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2232-2244
Closed Access | Times Cited: 11
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
Gi‐Ae Kim, Seogsong Jeong, Heejoon Jang, et al.
Liver Cancer (2023) Vol. 13, Iss. 4, pp. 426-437
Open Access | Times Cited: 11
Puerarin Induces Macrophage M2 Polarization to Exert Antinonalcoholic Steatohepatitis Pharmacological Activity via the Activation of Autophagy
Xiaoxue Fang, Xintian Lan, Ming Zhu, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 13, pp. 7187-7202
Closed Access | Times Cited: 4
Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial
Maria Magdalena Quetglas‐Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 754-754
Open Access | Times Cited: 4
The Role of microRNA-22 in Metabolism
Simone Tomasini, Paolo Vigo, Francesco Margiotta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 782-782
Open Access
The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity
Ying Wang, Shuyi Yang, Suming Zhang, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
Lihui Zhang, Sutong Liu, Qing Zhao, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top